Imagine a creature so obscure that its very existence was only recorded by a German astronomer in 1719, and yet its absence has become a rallying cry for biotech firms with budgets in the millions. The bluebuck—a medium-sized antelope with a coat that shimmered like storm clouds—is now the centerpiece of Colossal Biosciences’ de-extinction ambitions. But what makes this story so compelling isn’t just the science, it’s the haunting irony of a species that vanished before modernity even had a camera. Personally, I think this reflects a deeper cultural fascination with resurrecting the past, even as we ignore the present. We’re obsessed with reviving creatures that died quietly, while the ones still struggling for survival are often written off as ‘common’ or ‘unremarkable.’
Let’s dissect the bluebuck’s tragic arc. It wasn’t a charismatic megafauna like the woolly mammoth; it was a grassland dweller, unremarkable to most until its habitat was razed by colonial agriculture. What many people don’t realize is that its extinction wasn’t a slow, inevitable decline—it was a sudden, human-driven collapse. A 2021 genetic study revealed that the bluebuck persisted in low numbers for millennia, only to vanish within decades of European settlers arriving. This pattern, I find deeply unsettling. It mirrors the fate of countless species today, from the Sumatran rhino to the vaquita. We keep repeating the same mistakes, just with newer tools and bigger budgets.
Colossal’s choice to resurrect the bluebuck isn’t just about nostalgia. The company frames it as a gateway to saving antelopes that are currently teetering on the edge. But here’s the thing: bringing back a species that’s been dead for centuries doesn’t exactly address the crisis of extinction in real time. In my opinion, this feels like a tech-driven distraction. While they’re sequencing genomes and cloning horns, 29 antelope species are still slipping toward oblivion. What does it say about our priorities that we’re more excited about reviving a ghost than protecting the living? It’s a bit like rebuilding the Titanic while the lifeboats are still sinking.
And then there’s the question of what the bluebuck even represents. The company calls it an ‘entry point’ into antelope conservation, but I wonder if they’re conflating symbolism with substance. The bluebuck’s story is one of extreme obscurity—its physical evidence is limited to a few disputed skins and no skulls. Yet it’s being marketed as a flagship for biodiversity. This raises a deeper question: Are we more interested in the spectacle of resurrection than the messy work of preservation? The fact that Stephen Jay Gould once called it the most obscure large mammal ever adds a layer of poetic tragedy. But what’s the point of resurrecting a creature if we don’t learn from its extinction?
Looking ahead, this effort could either be a breakthrough or a cautionary tale. If Colossal’s genome-editing techniques prove scalable, they might open doors for saving endangered species. But if they’re seen as a PR stunt, it could divert attention and funding from grassroots conservation. What makes this particularly fascinating is the tension between innovation and ethics. Should we be playing god with species that have already been lost, or should we focus on the ones still fighting for a chance? I suspect the answer lies somewhere in between, but the path forward will require more than just cloning—it’ll demand a reckoning with how we’ve treated the natural world all along.
